A treatment with cDDP alone, cDDP combined with either PARP1-i or HT, or cDDP combined with both induced a change in the steepness of the curve (Figure 5A), indicating that these treatments contributed to tumour control. The gene discussed is PARP1; the disease is neoplasm.